Pieter G. Postema MD, PhD

Dr. Pieter G. Postema, MD, PhD, is a certified cardiologist-electrophysiologist at the Heart Center of the Amsterdam University Medical Centers, The Netherlands, with a joint faculty appointment at the University of Amsterdam. Dr. Postema received both his undergraduate degree and medical degree cum laude at the Free University in Amsterdam and his philosopher’s degree also cum laude at the University of Amsterdam. During his medical training he performed research at the Department of Cardiology and the Rayne Institute at Guy’s, King’s and St Thomas’ School of Medicine, King’s College London, United Kingdom.

Dr. Postema is involved in the three academic pillars: patient care, medical education and research. His patient care particularly encompasses patients with arrhythmia and pacemakers or implantable defibrillators. This involves both outpatients, inpatients, as well as atrial and ventricular ablation procedures and implantations of pacemakers, defibrillators and cardiac resynchronization therapy. His medical education involves teaching cardiology, particularly electrocardiography and electrophysiology, to medical doctors, nurses, students, medical nurses, allied professionals, patients and their relatives, locally and internationally. The latter is exemplified by his involvement in the non-profit CardioNetworks Foundation devoted to improving free access to medical knowledge throughout the world. He also is the founder and director of BrugadaDrugs.org devoted to provide free worldwide access to knowledge on drug use in Brugada syndrome for medical professionals, patients and their relatives. His patient education particularly involves visual communication on cardiac disease with special focus on age, sex and ethnicity. His pre-clinical and clinical research is based on two intertwined topics, 1) the diagnosis, pathophysiological mechanisms, and treatment of malignant cardiac arrhythmias (i.e ventricular tachycardia and ventricular fibrillation) both in inheritable and acquired cardiac disease, and 2) electrocardiography in inheritable and acquired cardiac disease and on the population level with special focus on age, sex and ethnicity.